<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="39145">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02596789</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A00316-37</org_study_id>
    <nct_id>NCT02596789</nct_id>
  </id_info>
  <brief_title>Cortical Excitability Using Transcranial Magnetic Stimulation and Neuronavigation Device</brief_title>
  <acronym>RC-TMS</acronym>
  <official_title>Study of Cortical Excitability in Healthy Subjects With Transcranial Magnetic Stimulation (TMS) and a Neuronavigation Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has two main goals :

        -  to investigate the impact of aging on cortical excitability (CE)

        -  to investigate the impact of &quot;state dependency&quot; on CE, using a cognitive task and an
           emotional one.

      A Neuronavigation system of transcranial magnetic stimulation is used, and electromyographic
      response are recorded.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amplitudes of Motor evoked Potentials (µV) for ICI and ICF.</measure>
    <time_frame>Participants will be followed for an expected average of one month</time_frame>
    <description>Motor Evoked Potential (MEP) from the first dorsal interosseous are register during the stimulations.
Intracortical Inhibition (ICI) and Facilitation (ICF) are a paired-pulse TMS measure of cortical excitability. A short Interval interstimuli (2ms) leads to a cortical inhibition, which reflects the GABAergic neurotransmission; whereas a longer interval interstimuli leads to a cortical facilitation, which reflects glutamatergic neurotransmission.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Durations of Cortical Silent Period (ms)</measure>
    <time_frame>Participants will be followed for an expected average of one month</time_frame>
    <description>Cortical Silent Period (CSP) is a single-pulse TMS measure of cortical inhibition, stimulations are applied while subjects are exerting a muscular contraction of the thum-index pinch and lead to a muscular cancellation. Duration of this silence is measured.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>state dependency TMS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>TMS performed at rest and during a cognitive/emotional task</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TMS &quot;Magpro®, Magventure Inc&quot; device</intervention_name>
    <arm_group_label>state dependency TMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female

          -  age 18-75

          -  signed informed consent

          -  normal physical examination

        Exclusion Criteria:

          -  less 18 or more 75 years of age

          -  contra indication to TMS: epilepsia or seizures, metallic head devices, cardiac
             pacemaker, pregnancy, jet lag or severe insomnia the night before

          -  severe physical disease

          -  treatment with psychotropic drugs

          -  overt psychiatric disease

          -  alcohol consumption before the examination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thierry BOUGEROL, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lysianne BEYNEL, PhD student</last_name>
    <phone>33 4 76 76 54 11</phone>
    <email>lysianne.beynel@upmf-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christian MARENDAZ, PhD</last_name>
    <phone>33 4 76 82 59 26</phone>
    <email>christian.marendaz@upmf-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Psychiatry &amp; Neurology - University Hospital Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lysianne BEYNEL, PhD student</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>November 3, 2015</lastchanged_date>
  <firstreceived_date>July 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
